Colchicine Applications in COVID-19 Treatment
Summary
Colchicine, a long-established anti-inflammatory agent primarily used in gout and pericarditis, has been repurposed as a potential therapy against COVID-19. Its mechanism of action centres on disruption of microtubule polymerisation and inhibition of inflammasome activation, thereby limiting the release of interleukins and other pro-inflammatory cytokines implicated in severe viral disease. Early observational studies suggested a reduction in hospitalisation and mortality, prompting a range of clinical trials across inpatient and community settings. Evidence to date indicates a nuanced efficacy profile: benefits appear more pronounced in certain subpopulations or when administered early in the disease course, while large hospital-based trials have not demonstrated a clear mortality advantage. Colchicine’s oral route of administration, low cost and established safety record make it an attractive option for low-resource settings, though gastrointestinal adverse effects remain the principal concern. Ongoing analyses aim to delineate optimal dosing regimens, identify patient groups most likely to benefit and clarify its role alongside emerging antiviral and immunomodulatory therapies.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Colchicine Applications in COVID-19 Treatment publication trend
The graph below shows the total number of articles in colchicine applications in covid-19 treatment across all publications each year (not limited to Nature Index journals).
Technical terms
Meta-analysis: A statistical technique that combines results from multiple studies to estimate overall treatment effects.
Odds ratio: A measure of association indicating the odds of an outcome occurring with an exposure compared to without.
Randomised controlled trial: An experimental study design where participants are randomly allocated to intervention or control groups to minimise bias.
Composite endpoint: A single outcome measure combining two or more clinical events to capture overall treatment impact.
References
- Does colchicine reduce mortality in patients with COVID-19 clinical syndrome? An umbrella review of published meta-analyses. Heliyon (2023).
- Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Respiratory Medicine (2021).
- Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. The Lancet Respiratory Medicine (2021).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.